Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Sana Biotechnology, Inc. (SANA) had Free Cash Flow of $-71.81M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-63.63M |
|
-- |
|
-- |
|
$65.42M |
|
$-65.42M |
|
$1.78M |
|
$-63.63M |
|
$-63.63M |
|
$-63.63M |
|
$-63.63M |
|
$-63.63M |
|
$-63.63M |
|
$-65.42M |
|
$-63.19M |
|
295.67M |
|
295.67M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$170.63M |
|
$25.16M |
|
$260.89M |
|
$431.52M |
|
$123.75M |
|
-- |
|
$153.20M |
|
$276.95M |
|
$154.57M |
|
$-45.25M |
|
$154.57M |
|
299.31M |
|
| Cash Flow Statement Financials | |
$-70.17M |
|
$-38.08M |
|
$93.45M |
|
$76.06M |
|
$61.27M |
|
$-14.80M |
|
$11.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-71.81M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.17% |
|
140.62% |
|
-14.75% |
|
-41.17% |
|
$0.52 |
|
$-0.24 |
|
$-0.24 |
|